R1780
RPMI-1640 培养基
With ʟ-glutamine, sodium bicarbonate without arginine, leucine, lysine, and phenol red, liquid, sterile-filtered, suitable for cell culture, suitable for isotope labeling for cell culture applications
别名:
RPMI 1640 细胞培养基
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
产品名称
RPMI-1640 培养基, With L-glutamine and sodium bicarbonate. Without arginine, leucine, lysine, and phenol red, liquid, sterile-filtered, suitable for cell culture, designed for isotope labeling for cell culture applications
Quality Level
sterility
sterile-filtered
form
liquid
technique(s)
cell culture | mammalian: suitable
impurities
endotoxin, tested
components
NaHCO3: 2 g/L
phenol red: no
glucose: 2 g/L (Dextro)
L-glutamine: 0.3 g/L
shipped in
ambient
storage temp.
2-8°C
General description
RPMI-1640培养基是在1966年由Moore及其同事在Roswell Park Memorial Institute开发的。该培养基通过对McCoy的5A培养基进行改良配制而成，用于在悬浮培养中支持淋巴母细胞生长，但后来经证还可支持各种不同贴壁依赖性细胞。RPMI 1640最初配合血清补充剂使用，但经证在无血清的情况下也能支持多种细胞系。它还广泛应用于杂交细胞融合方案和生长。该培养基适用于人正常白细胞和肿瘤白细胞=培养。
Preparation Note
设计用于细胞培养应用中氨基酸稳定同位素标记。
补充 0.100 g/L L -精氨酸- 13 C 6 、 15 N 4 HCl（产品 608033）、0.100 g/L L -亮氨酸- 13 C 6 、 15 N（产品 608068）和 0.100 g/L L -赖氨酸- 13 C 6 、 15 N 2（产品 608041）。
补充 0.100 g/L L -精氨酸- 13 C 6 、 15 N 4 HCl（产品 608033）、0.100 g/L L -亮氨酸- 13 C 6 、 15 N（产品 608068）和 0.100 g/L L -赖氨酸- 13 C 6 、 15 N 2（产品 608041）。
Still not finding the right product?
Explore all of our products under RPMI-1640 培养基
存储类别
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
相关内容
Instructions
Guokai Yan et al.
Scientific reports, 7(1), 1914-1914 (2017-05-17)
Leucine (Leu) is a multifunctional essential amino acid that plays crucial role in various cellular processes. However, the integral effect of Leu on the hepatic proteome remains largely unknown. Here, we for the first time applied an isobaric tags for
Zhang Xiao Ying et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 22(21), 5383-5393 (2016-11-03)
This study was performed to further our understanding of the biological and genetic basis of follicular lymphoma and to identify potential novel therapy targets. We analyzed previously generated whole exome sequencing data of 23 follicular lymphoma cases and one transformed
Rachel S Lee et al.
Neoplasia (New York, N.Y.), 21(4), 389-400 (2019-03-23)
Approximately 50% of prostate cancers harbor the TMPRSS2:ERG fusion, resulting in elevated expression of the ERG transcription factor. Despite the identification of this subclass of prostate cancers, no personalized therapeutic strategies have achieved clinical implementation. Kinases are attractive therapeutic targets
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| R1780-500ML | 04061836694500 |